ArticleDrugs - real world outcomes2023

Retrospective Observational Study of Outcomes in HER2-Positive Metastatic Breast Cancer (mBC) Patients Treated with Ado-Trastuzumab Emtansine (T-DM1) and Subsequent Treatments After T-DM1 in the United States.

Neelima Denduluri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.